Suppr超能文献

抗淋巴细胞亚群单克隆抗体诱导的皮肤同种异体移植的长期或永久存活。

Prolonged or permanent survival of skin allografts induced by monoclonal antibodies against lymphocyte subpopulations.

作者信息

Holán V, Hasek M

出版信息

Folia Biol (Praha). 1985;31(1):50-8.

PMID:2857666
Abstract

The effect of cytotoxic monoclonal antibodies against T lymphocyte subpopulations on skin allograft survival in mice was compared. Antibodies against cytotoxic lymphocytes (anti-Lyt-2.2) suppressed the allotransplantation reaction more effectively than antibodies against helper/inducer T lymphocytes (monoab anti-Lyt-1.2 and GK1.5). The suppressive effect of anti-Lyt-2.2 antibodies was comparable with that of the antibodies against the whole T lymphocyte population (monoab anti-Thy-1.2). Antibodies anti-Lyt-2.2 led up to a permanent survival (in 40% of animals) of H-2 incompatible skin allografts, when administered for long periods since the day of birth. The effect of the different antibodies, however, depends on the timing of application in relation to skin grafting. The results indicate that prolongation of survival and almost permanent tolerance of skin allografts can be obtained by the specific elimination of T lymphocyte subpopulations by the use of monoab and that Lyt-2 positive T lymphocytes play an important role in rejection allotransplantation reaction.

摘要

比较了针对T淋巴细胞亚群的细胞毒性单克隆抗体对小鼠皮肤同种异体移植存活的影响。针对细胞毒性淋巴细胞的抗体(抗Lyt-2.2)比针对辅助/诱导性T淋巴细胞的抗体(单克隆抗Lyt-1.2和GK1.5)更有效地抑制了同种异体移植反应。抗Lyt-2.2抗体的抑制作用与针对整个T淋巴细胞群体的抗体(单克隆抗Thy-1.2)相当。自出生之日起长期给予抗Lyt-2.2抗体,可使H-2不相容的皮肤同种异体移植永久存活(40%的动物)。然而,不同抗体的效果取决于与皮肤移植相关的应用时间。结果表明,通过使用单克隆抗体特异性消除T淋巴细胞亚群,可以延长皮肤同种异体移植的存活时间并获得几乎永久的耐受性,并且Lyt-2阳性T淋巴细胞在同种异体移植排斥反应中起重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验